Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2000-11-01
2002-12-03
Rose, Shep K. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S178000, C514S182000
Reexamination Certificate
active
06489313
ABSTRACT:
FIELD OF THE INVENTION
The invention relates to the use of pharmaceuticals and dietary supplements to improve memory.
BACKGROUND
Mankind has sought ways to improve memory for years, including efforts ranging from the consumption of specific foods to meditation. While certain of these techniques have demonstrated limited success in improving memory, the search continues for alternative means for improving memory.
SUMMARY OF THE INVENTION
We have discovered that the memory of both a healthy mammal and a mammal with age impaired memory can be improved by administering an effective amount of &Dgr;5-Androstene-3&bgr;-ol-7,17-dione and 3&bgr; esters thereof.
REFERENCES:
patent: 4791099 (1988-12-01), Aroonsakul
patent: 4812447 (1989-03-01), Roberts
patent: 5292730 (1994-03-01), Lardy
patent: 5296481 (1994-03-01), Lardy
patent: 5424463 (1995-06-01), Lardy
patent: 5506223 (1996-04-01), Lardy
patent: 5556847 (1996-09-01), Johnson et al.
patent: 5585371 (1996-12-01), Lardy
patent: 5641766 (1997-06-01), Lardy
patent: 5707983 (1998-01-01), Lardy
patent: 5807848 (1998-09-01), Lardy
patent: 6153606 (2000-11-01), Lardy et al.
patent: 0 648 842 (1995-04-01), None
patent: WO 92/03925 (1992-03-01), None
patent: 92 03 925 (1992-03-01), None
patent: WO 94/03176 (1994-02-01), None
patent: 9403176 (1994-03-01), None
patent: 95 06 472 (1995-03-01), None
patent: WO 95/06472 (1995-03-01), None
patent: WO 96/12810 (1996-05-01), None
patent: WO 97/37664 (1997-10-01), None
Shi et al FASEB Journal 12(5): A 764, Mar. 20, 1998.*
Flood et al Brain Research 447: 269-278, 1988.*
Flood et al Brain Research 488: 178-181, 1988.*
Wolf et al JL. Clin.Endocrinol. & Metab. 82(7):2363-2367, Jul. 1997.*
Huppert, F.A., et al., “Dehydroepiandrosterone(DHEA)supplementation for cognition and well-being”, (Cochrane Review)The Cochrane Library, Issue 2, 1998.
Steen, G., et al., “Cognitive funtion in 70-year-old men and women. A 16-year cohort difference population study”, Aging Clin. Exp. Res. vol. 10: pp, 120-126 (1998).
Brébion, G., et al., “Memory impairment and schizophrenia: the role of processing speed”, Schizophrenia Research, vol. 30, pp. 31-39 (1998).
Rhodes, M., “Effects of Steroid Sulfatase Inhibition on Memory, Hippocampal Acetylcholine Release and Endogenous Neurosteroid Concentrations”, a dissertation presented to the Graduate School of Pharmaceutical Sciences of Duquesne University, Aug. 1997.
Rhodes, M., “The Effect of Dehydroepiandrosterone Sulfate and the Steroid Sulfatase Inhibitor Estrone-3-o-Sulfamate on Memory in Rats”, presented to the Graduate School of Pharmaceutical Sciences of Duquesne University, Oct. 1995.
Carlson, L., “Steroid Hormones and Memory in Healthy Elderly Men, in Women strogen-Users and Non-users and in Patients with Alzheimer's Disease”, presented to the Department of Psychology, McGill University, Aug. 1997.
Weeks, C., et al., “Preclinical toxicology evaluation of 3-acetyl-7-oxo-dehydroepiandrosterone (7-keto DHEA)”,The FASEB Journal, Abstracts Part II, vol. 12, No. 5, p. A764, Abstract No. 4428 (1998).
Davidson, M.H., et al., “Safety and endocrine effects of 3-acetyl-7-oxo-DHEA (7-keto-DHEA)”,The FASEB Journal, Abstracts Part II, vol. 12, No. 5, p. A764, Abstract No. 4429 (1998).
Rosenberg, D.R., et al., “Cognitive Enhancing Agents for the Treatment of Senile Dementia of the Alzheimer's Type”,Drugs of Today, vol. 28, No. 7, pp. 459-471 (1990).
Shi, J. et al., “3&bgr;-Hydoxyandrost-5-ene-7,17-dione (7-Keto-DHEA) Improves Memory in Mice,”The FASEB Journal, vol. 12, No. 5, Mar. 20, 1998, p. A764.
“Easing the Aches of Aging,”Star Tribune, vol. XIII, No. 283, Thursday, Jan. 12, 1995, p. 1A, 13A.
Akwa, Yvette et al., “Astrocytes and Neurosteroids: Metabolism of Pregnenolone and Dehydroepiandrosterone. Regulation by Cell Density,”The Journal of Cell Biology, vol. 121, No. 1, Apr. 1993, p. 135-143.
Barrou, Zina et al., “Dehydroepiandrosterone (DHEA) and Aging,”Archives of Gerontology and Geriatrics, Vo.. 24, No. 3, (1997), p. 233-241.
Bologa, L. et al., “Dehydroepiandrosterone and Its Sulfated Derivative Reduce Neuronal Death and Enhance Astrocytic Differentiation in Brain Cultures,”Journal of Neuroscience Research, vol. 17 (1987), p. 225-234.
Danenburg, H.D., “Dehydroepiandrosterone (DHEA) Increases Production and Release of Alzheimer's Amyloid Precursor Protein,”Life Sciences, vol. 59, No. 19 (1996), p. 1651-1657.
Dubrovsky, B., “Natural Steroids Counteracting Some Actions of Putative Depressogenic Steroids on the Central Nervous System: Potential Therapeutic Benefits,”Medical Hypotheses, vol. 49, (1997), p. 51-55.
Flood, James F., et al., “Dehydroepiandrosterone and Its Sulfate Enhance Memory Retention in Mice,”Brain Research, vol. 447 (1988), p. 269-278.
Flood, James F., et al., “Memory-Enhancing Effects in Male Mice of Pregnenolone and Steroids Metabolically Derived from It,”Proc. Natl. Acad. Sci., vol. 89, Mar. 1992, p. 1567-1571.
Gorman, Christine, “Can This Pill Really Make You Younger,”Time, Sep. 23, 1996, p. 66-67.
Jaroff, Leon, “New Age Therapy,”Time, Jan. 23, 1995, p. 52.
Maurice, Tangui, et al., “Dehydroepiandrosterone Sulfate Attenuates Dizocilpine-Induced Learning Impairments in Mice via &sgr;1-Receptors,”Behavioral Brain Research, vol. 83, No. 1 and 2, Feb. 1997, p. 159-164.
Wolf, Oliver T., et al., “Effects of a Two-Week Physiological Dehydroepiandrosterone Substitution on Cognitive Performance and Well-Being in Healthy Elderly Women and Men,”Journal of Clinical Endocrinology and Metabolism, vol. 82, No. 7, Jul. 1997, p. 2363-2367.
McVicar, Nancy, “DHEA, Touted as Fountain of Youth, Still has Its Share of Skeptics,”St. Paul Pioneer Press, Tuesday, Dec. 3, 1996, p. 1D, 2D.
Akwa, Yvette et al., “Neurosteroid Metabolism,”Biochem. Journal, vol. 288, (1992), p. 959-964.
Regelson, Willaim et al., “Dehydroepiandrosterone (DHEA)-the Multifunctional Steroid,”Annals of the New York Academy of Sciences, vol. 719 (1994), p. 564-575.
Shealy, C. Norman, “A Review of Dehydroepiandrosterone (DHEA),”Integrative Physiological and Behavioral Science, vol. 30, No. 4, Sep.-Dec. 1995, p. 308-313.
Starka, Lubos et al., “7-Hydroxylation of Dehyroepiandrosterone by Rat-Liver Homogenate,”Biochimica et Biophysica Acta, vol. 56, (1962) p. 76-82.
Sunderland, Trey et al., “Reduced Plasma Dehydroepiandrosterone Concentrations in Alzheimer's Disease,”The Lancet, Sep. 2, 1989, p. 570.
Regelson, William et al., “Hormonal Intervention: ‘Buffer Hormones’ or ‘State Dependency’”,Annals of the New York Academy of Science, vol. 521, (1988), p. 260-273.
Svec, Frank, et al., “Antiglucocorticoid Actions of Dehydroepiandrosterone and Low Concentrations in Alzheimer's Disease,”The Lancet, Dec. 2, 1989, p. 1335-1336.
Wolf, Oliver T., et al., “A Single Administration of Dehydroepiandrosterone Does Not Enhance Performance in Young Healthy Adults, but Immediately Reduces Cortisol Levels,”Biol. Psychiatry, vol. 42 (1997), p. 845-848.
Wolkowitz, Owen et al., “Dehydroepiandrosterone (DHEA) Treatment of Depression,”Biological Psychiatry, vol. 41, No. 3, Feb. 1, 1997, p. 311-318.
“ “DHEA” The Closet Thing to the Fountain of Youth,”Bio./Tech News.
“Humanetics Receives U.S. and Japanese Patents for the Use of 7-Keto DHEA to Mitigate the Effects of Alzheimer's,”Teltech Sentry Intelligence Service, Mar. 25, 1998, p. 7.
“Humaneties to Sponsor Paper on 7-Keto DHEA to Augment Memory Function,”Teltech Sentry Intelligence Service, Mar. 25, 1998, p. 6.
Brainum, Jerry, “DHEA The Mother of All Steroids,”IM, Sep. 1996, p. 101-107.
Flood, James F. et al., “Dehydroepiandrosterone Sulfate Improves Memory in Aging Mice,”Brain Research, vol. 488, (1988), p. 178-181.
McClain, Carla, “Anti-Aging Pill Shows Promise,”Tuscon Citizen, p. 1A, 10 A.
Rosenberg, David R. et al., “Cognitive Enhancing Agents for the Treatment of Senile Dementia of the Alzheimer's Type,”Medicamentos de Actualidad, vol. 26, No. 7, Oct./Nov. 1990, p. 449-471.
Lardy Henry A.
Shi Jennifer Y.
Humanetics Corporation
Rose Shep K.
LandOfFree
Memory by the administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Memory by the administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memory by the administration of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2985309